Intracranial Neoplasm
17
4
4
6
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
11.8%
2 terminated out of 17 trials
75.0%
-11.5% vs benchmark
0%
0 trials in Phase 3/4
17%
1 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (17)
Fluoroethyltyrosine for Evaluation of Intracranial Neoplasms
Hypofractionated Proton Therapy for Benign Intracranial Brain Tumors, the HiPPI Study
Oxygen-Enhanced MRI for Generating Hypoxia Maps in Patients With Intracranial Tumors
Using a Head and Neck Maskless Immobilization Device For Patients With Intracranial Tumors
Fluoroethyltyrosine for the Evaluation of Intracranial Neoplasm
Accuracy of Robotically Assisted Cranial Biopsies
[18F]DASA-23 and PET Scan in Evaluating Pyruvate Kinase M2 Expression in Patients With Intracranial Tumors or Recurrent Glioblastoma and Healthy Volunteers
The Relationship of Anesthesia Method With Serum Lactate Level in Craniotomies
Evaluation of Performance Characteristics and Applicability in Oncology of Devices Customized Medical Devices Made by 3D Printing
Comparison of Opioid Consumption During TCI Guided by NOL Index or Standard Care Undergoing Intracranial Tumor Surgery
Characterization of Human Autoantibody Titers After Central Nervous System Insult
Tractography Pilot Study Leipzig
QSM and Regional DCE MRI Permeability Using GOCART Technique
Intracranial Hydatid Cyst
The Effectiveness and Safety of Human Lumbar Puncture Assist Device (LPat)
Application of New Technologies in the Resection of Intracranial Tumors
The Effect of Cerebral Oxygenation on Postoperative Recovery in Intracranial Surgery